1. Home
  2. IBRX vs CHWY Comparison

IBRX vs CHWY Comparison

Compare IBRX & CHWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$6.09

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Logo Chewy Inc.

CHWY

Chewy Inc.

N/A

Current Price

$19.73

Market Cap

8.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
IBRX
CHWY
Founded
2014
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.8B
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
IBRX
CHWY
Price
$6.09
$19.73
Analyst Decision
Strong Buy
Buy
Analyst Count
4
27
Target Price
$14.25
★ $28.35
AVG Volume (30 Days)
★ 12.0M
6.0M
Earning Date
11-09-2026
12-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.71
N/A
EPS
N/A
★ 0.42
Revenue
$113,288,000.00
★ $12,601,500,000.00
Revenue This Year
$99.98
$7.32
Revenue Next Year
$108.29
$6.74
P/E Ratio
★ N/A
$48.46
Revenue Growth
★ 668.31
6.24
52 Week Low
$1.95
$17.40
52 Week High
$12.43
$37.34

Technical Indicators

Market Signals
Indicator
IBRX
CHWY
Relative Strength Index (RSI) 36.40 37.23
Support Level N/A $17.49
Resistance Level $8.62 $22.31
Average True Range (ATR) 0.57 0.85
MACD -0.10 -0.38
Stochastic Oscillator 10.19 0.47

Price Performance

Historical Comparison
IBRX
CHWY

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About CHWY Chewy Inc.

Founded in 2011, Chewy is a leading e-commerce retailer of pet food, toys, supplies, and medications in North America. The firm offers a comprehensive selection of proprietary and third-party brands, anchored by its highly sticky autoship subscription program, which drives over 83% of its sales. Beyond core retail, Chewy is expanding into high-margin revenue streams, including its retail media network (Chewy Ads), specialized veterinary healthcare software, and brick-and-mortar veterinary clinics to further integrate customers into the Chewy ecosystem.

Share on Social Networks: